A pharmacotherapy review of the novel, oral antithrombotics

Kara J. Walters, Anna Meador, John A. Galdo, Katharine Ciarrocca

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Coagulation disorders account for a high incidence of death in the U.S. due to stroke, myocardial infarction, and venous thromboembolism. In the past few years, numerous agents have been brought to market for the treatment of thromboembolism or prevention of thromboembolism. Similar to warfarin, these agents can cause bleeding disorders, which may exacerbate dental care treatment plans. This literature review examines the newer agents for the treatment of thromboembolism disorders, common side effects and drug interactions, the specific medical conditions each agent treats, and the dental perspective on how to medically management patients prescribed these medications.

Original languageEnglish (US)
Pages (from-to)62-70
Number of pages9
JournalSpecial Care in Dentistry
Issue number2
StatePublished - Mar 1 2017
Externally publishedYes


  • anticoagulation
  • medical management
  • pharmacy
  • surgery

ASJC Scopus subject areas

  • General Dentistry


Dive into the research topics of 'A pharmacotherapy review of the novel, oral antithrombotics'. Together they form a unique fingerprint.

Cite this